HIKAL Financial Statement Analysis
|
||
|
The Revenues of HIKAL have decreased by -7.91% YoY .
The Earnings Per Share (EPS) of HIKAL has decreased by Negative YoY. |
||
HIKAL Last 5 Annual Financial Results
[BOM: 524735|NSE : HIKAL]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹1,713 Cr | ₹1,860 Cr | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr |
| Expenses | ₹1,492 Cr | ₹1,531 Cr | ₹1,518 Cr | ₹1,766 Cr | ₹1,602 Cr |
| Operating Profit (Excl OI) | ₹220 Cr | ₹328 Cr | ₹267 Cr | ₹257 Cr | ₹341 Cr |
| Other Income | ₹12 Cr | ₹5.00 Cr | ₹2.50 Cr | ₹5.41 Cr | ₹4.89 Cr |
| Interest | ₹62 Cr | ₹75 Cr | ₹56 Cr | ₹48 Cr | ₹31 Cr |
| Depreciation | ₹164 Cr | ₹134 Cr | ₹118 Cr | ₹109 Cr | ₹96 Cr |
| Profit Before Tax | ₹-78 Cr | ₹124 Cr | ₹96 Cr | ₹105 Cr | ₹219 Cr |
| Profit After Tax | ₹-49 Cr | ₹91 Cr | ₹70 Cr | ₹78 Cr | ₹160 Cr |
| Consolidated Net Profit | ₹-49 Cr | ₹91 Cr | ₹70 Cr | ₹78 Cr | ₹160 Cr |
| Earnings Per Share (Rs) | ₹-3.95 | ₹7.35 | ₹5.64 | ₹6.36 | ₹13.02 |
| PAT Margin (%) | -2.85 | 4.88 | 3.90 | 3.87 | 8.26 |
| ROE(%) | -3.97 | 7.41 | 6.00 | 7.12 | 16.04 |
| ROCE(%) | -0.83 | 9.88 | 7.82 | 8.47 | 15.21 |
| Total Debt/Equity(x) | 0.57 | 0.60 | 0.69 | 0.66 | 0.63 |
Key Financials |
||
| Market Cap | : | ₹ 2,618.3 Cr |
| Revenue (TTM) | : | ₹ 1,735.0 Cr |
| Net Profit(TTM) | : | ₹ -33.8 Cr |
| EPS (TTM) | : | ₹ -2.7 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HIKAL | -13.8% | -2.6% | -14.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.5% | -4.7% | 15.5% |
| DIVIS LABORATORIES | -4% | 8.1% | 55.4% |
| TORRENT PHARMACEUTICALS | -2.3% | 0.2% | 36.6% |
| CIPLA | -1.7% | -6.1% | -12% |
| DR REDDYS LABORATORIES | -0.2% | -4.4% | -10.2% |
| MANKIND PHARMA | -0.8% | -5.4% | -12.1% |
| LUPIN | -2.7% | -8% | 7% |
| ZYDUS LIFESCIENCES | -4.4% | -3.6% | 8% |
HIKAL Revenues
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -7.91 % |
| 5 Yr CAGR | -3.10 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,713 Cr | -7.91 | |
| Mar2025 | ₹1,860 Cr | 4.21 | |
| Mar2024 | ₹1,785 Cr | -11.79 | |
| Mar2023 | ₹2,023 Cr | 4.13 | |
| Mar2022 | ₹1,943 Cr | - | |
HIKAL Operating Profit
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -32.89 % |
| 5 Yr CAGR | -10.31 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹220 Cr | -32.89 | |
| Mar2025 | ₹328 Cr | 23.00 | |
| Mar2024 | ₹267 Cr | 3.86 | |
| Mar2023 | ₹257 Cr | -24.51 | |
| Mar2022 | ₹341 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -27.12 % |
| 5 Yr CAGR | -7.43 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 12.87% | -27.12 | |
| Mar2025 | 17.66% | 18.05 | |
| Mar2024 | 14.96% | 17.70 | |
| Mar2023 | 12.71% | -27.50 | |
| Mar2022 | 17.53% | - | |
HIKAL Profit After Tax
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹-49 Cr | Negative | |
| Mar2025 | ₹91 Cr | 30.46 | |
| Mar2024 | ₹70 Cr | -11.20 | |
| Mar2023 | ₹78 Cr | -51.16 | |
| Mar2022 | ₹160 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | -2.85 % | Negative | |
| Mar2025 | 4.88 % | 25.13 | |
| Mar2024 | 3.9 % | 0.78 | |
| Mar2023 | 3.87 % | -53.15 | |
| Mar2022 | 8.26 % | - | |
HIKAL Earnings Per Share (EPS)
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.95 | Negative | |
| Mar2025 | ₹7.35 | 30.32 | |
| Mar2024 | ₹5.64 | -11.32 | |
| Mar2023 | ₹6.36 | -51.15 | |
| Mar2022 | ₹13 | - | |
HIKAL Return on Capital Employed (ROCE)
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | -0.83% | Negative | |
| Mar2025 | 9.88% | 26.34 | |
| Mar2024 | 7.82% | -7.67 | |
| Mar2023 | 8.47% | -44.31 | |
| Mar2022 | 15.21% | - | |
HIKAL Share Price vs Sensex
| Current Share Price | : | ₹212.4 |
| Current MarketCap | : | ₹ 2,618.3 Cr |
| Updated EOD on | : | Sep 15,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -13.8% |
-2.6% |
-14.6% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
HIKAL related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -1.6% | -1.1% | 14.4% |
| BSE 1000 | -2.9% | -4.7% | -1.3% |
No NSE index found
You may also like the below Video Courses
FAQ about HIKAL Financials
How the annual revenues of HIKAL have changed ?
The Revenues of HIKAL have decreased by -7.91% YoY .
How the Earnings per Share (EPS) of HIKAL have changed?
The Earnings Per Share (EPS) of HIKAL has decreased by Negative YoY .
Check out Intrinsic Value of Peers of HIKAL
Compare Stock Analytics of Peers of HIKAL
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
